RENB-HB-01 / Seraph Research Institute, Lunai Bioworks - LARVOL DELTA

Enochian BioSciences Announces Its Successful Completion of FDA Pre-IND for a Potential Cure for Hepatitis B Virus Infection (GlobeNewswire) - "Enochian BioSciences, Inc...announced the completion of a Pre-Investigational New Drug (IND) process following receipt of written comments from the U.S. Food and Drug Administration (FDA) Center for Biologics Evaluation and Research (CBER) Office of Tissues and Advanced Therapies (OTAT)."

FDA event • Hepatitis B • Infectious Disease